title: Simultaneous induction of apoptosis, collagen type I expression and mineralization in the developing coronal suture following FGF4 and FGF2 application.
abstract: This study aimed to evaluate the disturbances in normal coronal suture development resulting in craniosynostosis, a congenital disorder in which the calvarial sutures close prematurely. Craniosynostosis syndromes can be caused by mutations in the genes encoding for the fibroblast growth factor receptors (FGFRs) 1, 2, and 3. These gain-of-function mutations cause the transcribed receptor to be constitutively activated. To mimic this genetic defect, fibroblast growth factor (FGF) 2 or 4 was administered near the developing coronal suture in normal mouse embryos through ex utero surgery. The effect on apoptosis and bone differentiation, as collagen type I expression and mineralization, within the FGF-exposed coronal suture was investigated through (immuno)histochemical staining. An increase in the number of apoptotic cells together with ectopic collagen type I expression within the suture and accelerated mineralization followed FGF application. Macroscopically, this presented as a synostotic coronal suture. These results suggest that both apoptosis and differentiation are two processes that are simultaneously implicated in synostosis of the coronal suture in case of a FGFR-related craniosynostosis.
authors.affiliation: Institute of Plastic Surgery at the Erasmus University  Rotterdam, The Netherlands. mathijssen@nvpc.nl
authors.forename: I M
authors.initials: IM
authors.lastname: Mathijssen
authors.forename: J P
authors.initials: JP
authors.lastname: van Leeuwen
authors.forename: C
authors.initials: C
authors.lastname: Vermeij-Keers
mesh_terms: D000367:Age Factors; D000818:Animals; D017209:Apoptosis / Q000187:drug effects; D002454:Cell Differentiation / Q000187:drug effects; D003094:Collagen / Q000096:biosynthesis*; D003398:Craniosynostoses / Q000378:metabolism; D016222:Fibroblast Growth Factor 2 / Q000494:pharmacology*; D005346:Fibroblast Growth Factors / Q000494:pharmacology*; D007150:Immunohistochemistry; D051379:Mice; D012886:Skull / Q000002:abnormalities* / Q000187:drug effects / Q000196:embryology; D013997:Time Factors
chemical_list: C112971:fibroblast growth factor 14; D016222:Fibroblast Growth Factor 2; D005346:Fibroblast Growth Factors; D003094:Collagen